@gbg.deWhen chemotherapy is considered, does it always have to come first?
That was the question behind the randomized #PADMA trial in patients with hormone receptor-positive (HR-positive), HER2-negative metastatic breast cancer.
Read the publication here:
www.sciencedirect.com/science/arti...
@toppnews.bsky.social